We report a case of Fusarium solani infection in a 2'2-year-old girl with acute lymphoblastic leukemia and severe neutropenia. The infection, initially limited to her sinuses, became disseminated, as evidenced by the development of a characteristic cutaneous lesion on her left leg after a cumulative dose of amphotericin B of 18.3 mg/kg. Amphotericin B lipid complex (ABLC), 5 mg/kg/day, in conjunction with repeated surgical debridement of the sinuses and correction of neutropenia with granulocyte colony stimulating factor (GCSF), led to clinical and mycologic cure.
Get full access to this article
View all access options for this article.
References
1.
1. Rabodinirina M, Piens MA, Monier MF, et al. Fusarium infections in immunocompromised patients: case reports and literature review. Eur J Clin Microbiol Infect Dis. 1994;13:152-161.
2.
2. Anaissie E, Kantarian H, Ro J, et al. The emerging role of Fusarium infections in patients with cancer. Medicine. 1988;67:77-83.
3.
3. Barrios NJ, Kirkpatrick DV, Murciano A, et al. Successful treatment of disseminated Fusarium infection in an immunocompromised child. Am J Pediatr Hematol Onco L1990;12:319-324.
4.
4. Gates C, Pinney RJ. Amphotericin B and its delivery by liposomal and lipid formulations. J Clin Pharm Ther. 1993;18:147-153.
5.
5. Lopez-Berestien G, Fainstein V, Hopfer R, et al. Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Infect Dis. 1985;151:704-710.
6.
6. Agamanolis DP, Kalwinsky DK, KrillJr CE, et al. Fusarium meningoencephalitis in a child with acute leukemia. Neuropediatrics. 1991;22:110-112.
7.
7. Zaias N. Superficial white onychomycosis. Sabouraudia. 1966;5:99-103.
8.
8. Zapater RC, Arrechea A. Mycotic keratitis by Fusarium. A review and report of two cases. Ophthalmologica. 1975; 170:1-12.
9.
9. Louie T, el Baba F, Shulman M, Jimenez-Lucho V. Endogenous endophthalmitis due to Fusarium: case report and review. Clin Infect Dis. 1994;18:585-588.
10.
10. Steinberg GK, Britt RH, Enzmann DR, et al. Fusarium brain abscess. Case Report.J Neurosurg. 1983;58:598-601.
11.
11. Cho CT, Vats TS, Lowman JT, et al. Fusarium solani infection during treatment for acute leukemia. J Pediatr. 1973;83:1028-1031.
12.
12. Hsu CM, Lee P, Chen J, et al. Fatal Fusarium endocarditis complicated by hemolytic anemia and thrombocytopenia in an infant. PediatrInfectDisj1994;13:1146-1147.
13.
13. Jakle C, Leek JC, Olson DA, Robbins DL. Septic arthritis due to Fusarium solani.J RheumatoL1983;10:151-153.
14.
14. Kerr CM, Perfect JR, Craven PC, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med. 1983;99:334-337.
15.
15. Englehard D, Eldor A, Polachek I, et al. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex. Leuk Lymphoma. 1993;9:385-392.
16.
16. Madhavan M, Ratnakar C, Veliath AJ, et al. Primary disseminated fusarial infection. J Postgrad Med. 1992;68:143-144.
17.
17. Kurien M, Anandi V, Raman R, Brahmadathan KN. Maxillary sinus fusariosis in immunocompetent hosts. J Laryngol OtoL1992;106:733-736.
18.
18. Gamis AS, Gudnason T, Giebink GS, Ramsay NKC. Disseminated infection with Fusarium in recipients of bone marrow transplants. Rev Infect Dis. 1991;13:1077-1088.
19.
19. Holmberg K, Meyer, RD. Diagnosis and Therapy of Systemic Fungal Infections. New York: Raven Press; 1989: 8-8,55-55.
20.
20. Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect. 1994;28 (Suppl 1):7-15.
21.
21. Lupinetti FM, Giller RH, Trigg ME. Operative treatment of Fusarium fungal infection of the lung. Ann Thorac Surg. 1990;49:991-992.
22.
22. Wolff MA, Ramphal R. Use of amphotericin B lipid complex for treatment of disseminated cutaneous Fusarium infection in a neutropenic patient. CLD. 1995;20:1568-1569.
23.
23. Summerbell RC, Richardson SE, Kane J.Fusarium proliferatum as an agent of disseminated infection in an immunosuppressed patient. J Clin Microbiol. 1988;26:82-87.
24.
24. Chaulk CP, Smith PW, Feagler JR, et al. Fungemia due to Fusarium solani in an immunocompromised child. Pediatr Infect Dis. 1986;5:363-366.
25.
25. DeMuri GP, Hostetter MK. Resistance to antifungal agents. Pediatr Clin North Am. 1995;42:665-685.
26.
26. Jones RS, Barman A, Suh B, et al. Successful treatment of aspergillus vertebral osteomyelitis with amphotericin B lipid complex. Infect Dis Clin Pract. 1995;4:237-239.
27.
27. Hospenthal DR, Byrd JC, Weiss RB. Successful treatment of invasive aspergillosis complicating prolonged treatment-related neutropenia in acute myelogenous leukemia with amphotericin B lipid complex. Med Pediatr OncoL1995;25:119-122.
28.
28. Janknegt R, Siem de Marie, BakkerWoudenberg IAJM, Crommelin DJA. Liposomal and lipid formulations of amphotericin B. Clin Pharmacokinet. 1992;23:279-291.
29.
29. Kline S, Larsen TA, Fieber L, et al. Limited toxicity of prolonged therapy with high doses of amphotericin B lipid complex. Clin Infect Dis. 1995; 21:1154-1158.
30.
30. Anaissie EJ, Ramphal R. Efficacy and safety of amphotericin B lipid complex (ABLC) in the treatment of patients with life-threatening fusariosis. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy 1994. Abstract M87, p. 248-248.
31.
31. Walsh TJ, Hiemenz JW, Seibel N, Anaissie EJ. Amphotericin B lipid complex in the treatment of 228 cases of invasive mycosis. Presented at the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy 1994. Abstract M69, p. 247-247.
